"I've always been the funny fat guy. Can I be the funny skinny guy?" the actor said Josh Gad shared that he’s taking a GLP-1 ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...

The media queen also confessed that she was reluctant to take a GLP-1 drug because she felt it was “the easy way out.” That ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Explore how GLP-1 agonists, originally for diabetes, could transform addiction treatment by reducing cravings.

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

As GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro gain popularity, doctors are observing a surge in patients ...

Biotech company Metsera, which develops weight-loss drugs and is backed by ARCH Venture Partners, said on Monday that it is ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...